Funder: National Institutes of Health

Due Dates (Anticipated): November 2026 (Full application deadline, projected)

Funding Amounts: $1,800,000 total program funding; ~2 awards expected; phased multi-year projects

Summary: Supports rigorous, milestone-driven functional validation of new therapeutic targets for Alzheimer’s Disease-Related Dementias (ADRD) to accelerate translational research.

Key Information: This opportunity is forecasted; applications are not yet being solicited.